A PharmaPhorum article featuring commentary from ICON's Dr. Nuala Murphy and Dr. James Cummings.
Read articleRelated information
Webpage
COVID-19 clinical operations
Blog
COVID-19 and respiratory devices
Blog
COVID-19 vaccine trials
Blog
Diagnostics on the frontlines of COVID-19
Blog
Minimise the impact of COVID-19 on clinical trials with in-home clinical services
Blog
Managing trial participants with cardiovascular and metabolic disease during COVID-19
Blog
COVID-19, Influenza and cardiovascular disease - What is known?
Blog